Providence Begins Novel Brain Tumor Vaccine Trial

Researchers Identify Key Pathway in Aggressive Pediatric Brain Cancer

Researchers have uncovered a genetic pathway that plays a major role in cancer cell growth. Better yet, they may even have a drug that fights it.

Celldex's Rindopepimut (Rintega(R)) Receives FDA Breakthrough Therapy Designation for the Treatment of Adult Patients with EGFRvIII-positive Glioblastoma

Celldex Therapeutics, Inc. (Nasdaq:CLDX) today announced that the U.S. Food and Drug Administration (FDA) has granted rindopepimut (Rintega®) Breakthrough Therapy Designation for the treatment of adult patients with EGFRvIII-positive glioblastoma (GBM).

Researchers Identify Promising New Target for Developing Better Therapies for Neuroblastoma Kids

Learn more about research for pediatric neuroblastoma.